Abstract 250P
Background
It is widely believed that nutritional and psychological disorders can affect the outcome of cancer treatment and the life quality of patients. However, the importance of nutritional and psychological interventions is still underestimated, and cancer treatment remains the main focus of clinical practice. In order to raise awareness of clinicians, we conducted a survey of nutritional and psychological status of cancer patients.
Methods
From December 2020 to January 2022, 1000 patients with advanced cancer completed the online survey of stardard nutritional and psychological scales.
Results
All the patients had solid tumors, and most(84.1%) of them had trouble in life quality caused by cancer treatment. The survey indicated 74.7% of the patients had at least once nutritional risk. Psychological disorders referred to three terms including insomnia, anxiety and depression. Patients experienced mild, moderate and severe insomnia was respectively 48.2%, 18.5% and 1.5%; mild, moderate and severe anxiety was respectively 57.5%, 25.5% and 3.3%; mild, moderate and severe depression was respectively 20.7%, 9.5% and 2.3%. Surprising 92.7% of the patients had never received any nutritional or psychological intervention.
Conclusions
There is an urgent need to assess the nutritional and psychological status of cancer patients in the early stage of treatment, and implement effective interventions to enable more patients to live longer and better.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
186P - Degradation of BRCA2 expression by hyperthermia sensitizes HRD-negative (BRCA2 wild-type) ovarian cancer cells to niraparib
Presenter: Junyang Li
Session: Poster viewing 03
187P - BUB1 (2530C>T) polymorphism and expression affects chemotherapy response and predicts poor prognosis in advanced epithelial ovarian cancer
Presenter: Sinjini Sarkar
Session: Poster viewing 03
188P - Spatial transcriptomic analysis of tumor tissue in ovarian cancer patients treated with neoadjuvant chemotherapy
Presenter: Irina Larionova
Session: Poster viewing 03
189P - LncRNA NKILA as a negative regulator of NFkB in ascites in ovarian cancer
Presenter: Dinara Dolgova
Session: Poster viewing 03
190P - Real-world applications of poly (ADP-ribose) polymerase inhibitors for ovarian cancer: A single-center study in China
Presenter: dengfeng wang
Session: Poster viewing 03
191P - Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
Presenter: N Thejeswar
Session: Poster viewing 03
192P - Human epididymis protein 4 as a predictor of response to neoadjuvant chemotherapy in epithelial ovarian cancer
Presenter: Sarada Planjery
Session: Poster viewing 03
193P - Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice: Experience of re-challenge mode of olaparib usage
Presenter: Alexander Sultanbaev
Session: Poster viewing 03
194P - A study of the treatment response of concomitant external beam radiotherapy (EBRT) and intracavitary brachytherapy in the management of locally advanced carcinoma of uterine cervix
Presenter: Asish Chowdhury
Session: Poster viewing 03
195P - Awareness of human papillomavirus (HPV) infection, cervical cancer (CC), and vaccine among females in Sultanate of Oman
Presenter: Abdulrahman Al-Mirza
Session: Poster viewing 03